Gyon Technologies Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,850
Closed -$266K 115
2022
Q4
$266K Sell
2,850
-49
-2% -$4.73K 0.1% 237
2022
Q3
$276K Sell
2,899
-1,500
-34% -$148K 0.09% 289
2022
Q2
$408K Buy
4,399
+1,949
+80% +$190K 0.11% 202
2022
Q1
$248K Sell
2,450
-7,021
-74% -$738K 0.17% 204
2021
Q4
$977K Buy
9,471
+6,818
+257% +$630K 0.18% 159
2021
Q3
$225K Sell
2,653
-9,209
-78% -$771K 0.06% 336
2021
Q2
$990K Buy
11,862
+6,704
+130% +$549K 0.32% 105
2021
Q1
$388K Sell
5,158
-9,984
-66% -$727K 0.17% 215
2020
Q4
$1.03M Sell
15,142
-1,952
-11% -$127K 0.36% 92
2020
Q3
$999K Buy
+17,094
New +$1.06M 0.78% 19

Other funds holding CVS

Gyon Technologies Capital Management's CVS Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,850 shares — an estimated $266K sold.

Gyon Technologies Capital Management first reported a position in CVS in Q3 2020 and held it in 10 quarters. The position peaked at $1.03M in Q4 2020. 2,268 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 2,850 CVS Health shares in Q1 2023, an estimated $266K.
  • Gyon Technologies Capital Management first reported a position in CVS Health in Q3 2020 and held it in 10 quarters.
  • Gyon Technologies Capital Management's CVS Health position peaked at $1.03M in Q4 2020.
  • 2,268 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.